March 23, 2025 - 05:50

Microchip Technology Inc. has announced the engagement of Macquarie Group to assist in the sale of its wafer fabrication facility located in Tempe, Arizona. This strategic move highlights the company's ongoing efforts to optimize its operations and focus on core business areas. The Tempe facility has been a significant part of Microchip's manufacturing capabilities, contributing to the production of various semiconductor products.
By partnering with Macquarie Group, Microchip aims to streamline the sale process and ensure that the transition is smooth and beneficial for all parties involved. The decision to sell the facility comes as the semiconductor industry continues to evolve, with companies seeking to adapt to changing market dynamics and customer demands.
Microchip Technology remains committed to maintaining its leadership position in the semiconductor sector while exploring opportunities that align with its long-term growth strategy. The sale of the Tempe facility marks a pivotal moment in the company's journey as it seeks to enhance operational efficiency and drive innovation.
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...